A cost function analysis of shigellosis in Thailand

Value in Health

Volumn 11, Issue SUPPL. 1, 2008, Pages

  Riewpaiboon, Arthorn ^a   Youngkong, Sitaporn ^b   Sreshthaputra, Nutta ^c   Stewart, John F ^d   Samosornsuk, Seksun ^e   Chaicumpa, Wanpen ^e   Von Seidlein, Lorenz ^f   Clemens, John D ^f  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e THAMMASAT UNIVERSITY   (Thailand)

^f International Vaccine Institute   (South Korea)

Author keywords

Cost function; Public treatment cost; Shigellosis

Indexed keywords

ADULT; BACTERIUM CULTURE; CONFERENCE PAPER; COST OF ILLNESS; DIARRHEA; FEMALE; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HEALTH INSURANCE; HOSPITAL MANAGEMENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SHIGELLA; SHIGELLOSIS; SOCIAL SECURITY; THAILAND;

EID: 41749104890     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00370.x     Document Type: Conference Paper

References (46)

1. Future needs and directions for Shigella vaccines. Wkly Epidemiol Rec 2006 6 : 51 8.
2. The Thai Working Group on burden attributable to risk factors MoPH. Thailand's Risk Burden in 1999. Bangkok : Bureau of Health Policy and Planning, Ministry of Public Health, 2004.
3. Epidemiology Bureau Ministry of Public Health. Annual Epidemiological Surveillance Report 2003. Available from: http://epid.moph.go.th/ [Accessed July 13, 2005].
4. Chompook P, Samosornsuk S, von Seidlein L, et al. Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bull World Health Organ 2005 83 : 739 46.
5. Lee H, Kotloff K, Chukaserm P, et al. Shigellosis remains an important problem in children less than 5 years of age in Thailand. Epidemiol Infect 2005 133 : 469 74.
6. Chen KT, Fan SF, Tang RB, et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan. Vaccine 2007 25 : 4266 72. Epub 2007 Mar 7.
7. Fischer TK, Anh DD, Antil L, et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005 192 : 1720 6.
8. Nelson EA, Tam JS, Yu LM, et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong. J Infect Dis 2005 192 (Suppl. 1 S64 70.
9. Ehrenkranz P, Lanata CF, Penny ME, et al. Rotavirus diarrhea disease burden in Peru: the need for a rotavirus vaccine and its potential cost savings. Rev Panam Salud Publica 2001 10 : 240 8.
10. Zimmerman CM, Bresee JS, Parashar UD, et al. Cost of diarrhea-associated hospitalizations and outpatient visits in an insured population of young children in the United States. Pediatr Infect Dis J 2001 20 : 14 9.
11. Thomson MA, Booth IW. Treatment of traveller's diarrhoea. Economic aspects. Pharmacoeconomics 1996 9 : 382 91.
12. National Health Security Office. Annual Report 2003. Bangkok : National Health Security Office of Thailand, 2004.
13. Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In : Drummond M, McGuire A, eds. Economic Evaluation in Health Care - Merging Theory with Practice. New York : Oxford University Press, 2001.
14. Oaks EV, Turbyfill KR. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. Vaccine 2006 24 : 2290 301.
15. Kobelt G. Health Economics: An Introduction to Economic Evaluation (2nd ed.). London : Office of Health Economics, 2002.
16. Bank of Thailand. Consumer price index by group. Available from: http://www.bot.or.th/bothomepage/databank/EconData/EconFinance/Download/Tab77. xls [Accessed April 20, 2007].
17. Bank of Thailand. Foreign exchange rates. Available from: http://www.bot.or.th/bothomepage/databank/FinMarkets/ExchangeRate/exchange_e. asp [Accessed February 5, 2007].
18. Samosornsuk S. The Burden of Shigellosis and Molecular Characteristics of Shigella spp. Isolated in Kaeng-khoi District, Saraburi Province, Thailand [PhD. in Biomedical Sciences]. Bangkok : Thammasart University, 2006.
19. Alpha Research, ed. Thailand Public Health 2006-2007. Nonthaburi : Alpha Research, 2006.
20. Sonjai K, Soisangwan R, Sakolvaree Y, et al. Validation of salmonellosis and shigellosis diagnostic test kits at a provincial hospital in Thailand. Asian Pac J Allergy Immunol 2001 19 : 115 27.
21. Manning WG, Fryback DG, Weinstein MC. Reflecting uncertainty in cost-effectiveness analysis. In : Gold MR, Sigel JE, Russell LB, et al., eds. Cost-Effectiveness in Health and Medicine. Oxford : Oxford University Press, 1996.
22. Cohen J, Cohen P, West SG, et al. Applied Multiple Regression/ ;Correlation Analysis for the Behavioral Sciences (3rd ed.). Mahwah, NJ : Lawrence Erlbaum Associates, Inc., 2003.
23. Duan N. Smearing estimator: a nonparametric retransformation method. J Am Stat Assoc 1983 78 : 605 10.
24. Smith M, Barnett P. What is retransformation bias, and how can it be corrected? Available from: http://www.herc.research.med.va.gov/ faqE2_retransformation.pdf [Accessed August 5, 2005].
25. Drummond M, O'Brien BJ, Stoddart GL, et al. Method for the Economic Evaluation of Health Care Programmes (2nd ed.). Oxford : Oxford University Press, 1997.
26. Rigden MJ. Health Service Financial and Accounting. London : Heinenann, 1983.
27. Riewpaiboon A, Malaroje S, Kongsawatt S. Effect of costing methods on unit cost of hospital medi cal services. Trop Med Int Health 2007 12 : 554 63.
28. Shepard DS, Hodgkin D, Anthony YE. Analysis of Hospital Costs: A Manual for Managers. Geneva : World Health Organization, 2000.
29. Kumaranayake L. The real and the nominal? Making inflationary adjustments to cost and other economic data. Health Policy Plan 2000 15 : 230 4.
30. Edejer TT-T, Baltussen R, Adam T, et al. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva : World Health Organization, 2003.
31. Creese A, Parker D. Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva : World Health Organization, 2000.
32. Disyathikom K, Pacharanarumol W, Tangcharoensathien V. A Manual of District Hospital Cost Analysis (in Thai Language). Bangkok : International Health Policy Planning, 2001.
33. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982 96 : 102 9.
34. Suver JD, Cooper JC. Principles and methods of managerial cost-accounting systems. Am J Hosp Pharm 1988 45 : 146 52.
35. Leaner WM, Wellman WL, Burik D. Pricing hospital units of service using microcosting techniques. Hosp Health Serv Adm 1985 30 : 7 28.
36. Zhou X-HA, Ramsey S. Assessing the equality of means of healthcare costs. Expert Rev Pharmacoeconomics Outcomes Res 2003 3 : 561 7.
37. Riewpaiboon A, Piyauthakit P, Chaikledkaew U. Economic burden of road traffic injuries: a micro-costing approach. 2008 submitted).
38. Assavasamrit N. Unit Cost of Outpatient and Inpatient Services at Lomkao Crown Prince Hospital, Petchaboon Province Fiscal Year 1998 [Master of Science in Pharmacy (Hospital Pharmacy)]. Bangkok : Mahidol University, 1999.
39. Riewpaiboon A, Jaroenkitpan N, Wipaswacharayotin Y. Cost structure of hospital-based pharmaceutical services: a consideration of reimbursement. Mahidol Univ J Pharm Sci 2005 32 : 47 54.
40. Youngkong S, Riewpaiboon A, Towanabut S, et al. Unit cost of medical services at Prasat Neurological Institute. Srinakarinwirot J Pharm Sci 2004 9 : 52 8.
41. Mogyorosy Z, Smith P. The Main Methodologyical Issues in Costing Health Care Services; a Literature Review. York : Centre for Health Economics, The University of York, 2005.
42. Bhattacharya SK, Sur D. An evaluation of current shigellosis treatment. Expert Opin Pharmacother 2003 4 : 1315 20.
43. Chompooka P, Todd J, Wheeler JG, et al. Risk factors for shigellosis in Thailand. Int J Infect Dis 2006 10 : 425 33.
44. Torrance GW, Siegel JE, Luce BR. Framing and designing the cost effectiveness analysis. In : Gold MR, Sigel JE, Russell LB, et al., eds. Cost-Effectiveness in Health and Medicine. Oxford : Oxford University Press, 1996.
45. Agro KE. Sensitivity analysis in health economic and pharmacoeconomic studies: an appraisal of the literature. Pharmacoeconomics 1997 11 : 75 88.
46. Briggs A, Sculpher M. Sensitivity analysis in economic evaluation: a review of published studies. Health Econ 1995 4 : 355 71.